Geode Capital Management
PFE icon

Geode Capital Management’s Pfizer PFE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.08B Buy
127,471,481
+1,820,634
+1% +$44M 0.22% 80
2025
Q1
$3.18B Buy
125,650,847
+5,061,065
+4% +$128M 0.25% 69
2024
Q4
$3.19B Buy
120,589,782
+2,923,537
+2% +$77.3M 0.25% 65
2024
Q3
$3.39B Buy
117,666,245
+1,855,419
+2% +$53.5M 0.27% 58
2024
Q2
$3.23B Buy
115,810,826
+2,229,188
+2% +$62.2M 0.28% 55
2024
Q1
$3.14B Buy
113,581,638
+4,047,421
+4% +$112M 0.29% 53
2023
Q4
$3.15B Buy
109,534,217
+2,448,393
+2% +$70.3M 0.33% 47
2023
Q3
$3.54B Sell
107,085,824
-5,786,682
-5% -$192M 0.42% 36
2023
Q2
$4.13B Buy
112,872,506
+3,019,727
+3% +$110M 0.49% 29
2023
Q1
$4.47B Buy
109,852,779
+577,201
+0.5% +$23.5M 0.58% 25
2022
Q4
$5.59B Sell
109,275,578
-1,166,562
-1% -$59.7M 0.78% 18
2022
Q3
$4.83B Buy
110,442,140
+1,859,302
+2% +$81.3M 0.73% 18
2022
Q2
$5.68B Buy
108,582,838
+3,684,436
+4% +$193M 0.83% 15
2022
Q1
$5.42B Buy
104,898,402
+3,833,329
+4% +$198M 0.68% 17
2021
Q4
$5.95B Buy
101,065,073
+1,471,980
+1% +$86.7M 0.72% 16
2021
Q3
$4.27B Buy
99,593,093
+3,211,904
+3% +$138M 0.58% 22
2021
Q2
$3.76B Buy
96,381,189
+2,233,072
+2% +$87.2M 0.52% 25
2021
Q1
$3.4B Buy
94,148,117
+3,699,308
+4% +$134M 0.52% 28
2020
Q4
$3.32B Buy
90,448,809
+1,235,353
+1% +$45.4M 0.56% 26
2020
Q3
$3.27B Buy
89,213,456
+70,293
+0.1% +$2.57M 0.64% 22
2020
Q2
$2.91B Sell
89,143,163
-810,722
-0.9% -$26.5M 0.62% 24
2020
Q1
$2.93B Buy
89,953,885
+910,123
+1% +$29.7M 0.76% 19
2019
Q4
$3.48B Buy
89,043,762
+1,630,039
+2% +$63.7M 0.73% 22
2019
Q3
$3.14B Buy
87,413,723
+2,332,421
+3% +$83.7M 0.73% 22
2019
Q2
$3.68B Buy
85,081,302
+1,070,454
+1% +$46.3M 0.89% 13
2019
Q1
$3.56B Buy
84,010,848
+8,801,937
+12% +$373M 0.92% 13
2018
Q4
$3.28B Buy
75,208,911
+7,055,791
+10% +$307M 1.01% 11
2018
Q3
$3B Buy
68,153,120
+1,402,589
+2% +$61.7M 0.84% 14
2018
Q2
$2.42B Sell
66,750,531
-147,749
-0.2% -$5.35M 0.74% 21
2018
Q1
$2.37B Buy
66,898,280
+3,774,503
+6% +$134M 0.77% 18
2017
Q4
$2.28B Buy
63,123,777
+1,881,570
+3% +$68M 0.77% 18
2017
Q3
$2.18B Buy
61,242,207
+1,472,358
+2% +$52.5M 0.81% 16
2017
Q2
$2B Buy
59,769,849
+453,005
+0.8% +$15.2M 0.79% 16
2017
Q1
$2.03B Buy
59,316,844
+3,355,386
+6% +$115M 0.83% 16
2016
Q4
$1.82B Buy
55,961,458
+2,663,931
+5% +$86.4M 0.84% 18
2016
Q3
$1.8B Buy
53,297,527
+2,228,452
+4% +$75.4M 0.91% 15
2016
Q2
$1.8B Sell
51,069,075
-95,661
-0.2% -$3.36M 0.98% 16
2016
Q1
$1.51M Buy
51,164,736
+94,148
+0.2% +$2.79K 0.8% 17
2015
Q4
$1.65B Sell
51,070,588
-310,902
-0.6% -$10M 0.94% 15
2015
Q3
$1.61B Buy
51,381,490
+562,353
+1% +$17.6M 0.98% 14
2015
Q2
$1.7B Buy
50,819,137
+430,841
+0.9% +$14.4M 0.97% 11
2015
Q1
$1.75B Buy
50,388,296
+455,818
+0.9% +$15.8M 1% 11
2014
Q4
$1.55B Buy
49,932,478
+1,467,817
+3% +$45.7M 0.92% 12
2014
Q3
$1.43B Sell
48,464,661
-281,527
-0.6% -$8.31M 0.93% 13
2014
Q2
$1.45B Sell
48,746,188
-522,331
-1% -$15.5M 0.93% 13
2014
Q1
$1.58B Buy
49,268,519
+94,178
+0.2% +$3.02M 1.06% 12
2013
Q4
$1.51B Buy
49,174,341
+1,830,473
+4% +$56.1M 1.04% 12
2013
Q3
$1.36B Buy
47,343,868
+1,236,923
+3% +$35.5M 1.09% 12
2013
Q2
$1.29B Buy
+46,106,945
New +$1.29B 1.14% 14